(Q44165064)

English

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

scientific article published on 11 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Megan E McNally

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Antonio Martinez

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Hooman Khabiri

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gregory Guy

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Anthony J Michaels

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

James Hanje

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Robert Kirkpatrick

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mark Bloomston

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Carl R Schmidt

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

11 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

923-928

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

https://scigraph.springernature.com/pub.10.1245/s10434-012-2639-1

0 references

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Hepatocellular carcinoma in Central Europe: prognostic features and survival

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2639-1

21 January 2018

Identifiers

10.1245/S10434-012-2639-1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dimensions Publication ID

0 references

release_vz5ckqsmmbh2zdkfmoopnqn36u

1 reference

https://api.fatcat.wiki/v0/release/vz5ckqsmmbh2zdkfmoopnqn36u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44165064&oldid=2107335021"